A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study

✍ Scribed by Schilder, R.J.; Sill, M.W.; Lankes, H.A.; Gold, M.A.; Mannel, R.S.; Modesitt, S.C.; Hanjani, P.; Bonebrake, A.J.; Sood, A.K.; Godwin, A.K.; Hu, W.; Alpaugh, R.K.

• Book ID: 123604142
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 189 KB
• Volume: 129
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2013.01.006